SPS
PFE icon

Susquehanna Portfolio Strategies’s Pfizer PFE Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.7M Sell
485,837
-1,989,924
-80% -$52.1M 0.19% 145
2026
Q1 		$69.5M Hold
2,475,761
– – 1.03% 5
2025
Q4 		$61.6M Hold
2,475,761
– – 0.95% 7
2025
Q3 		$63.1M Sell
2,475,761
-249,053
-9% -$6.15M 1% 6
2025
Q2 		$66M Buy
+2,724,814
New +$63.5M 1.44% 2

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Susquehanna Portfolio Strategies's PFE Position: Q2 2026 in Review

Susquehanna Portfolio Strategies reduced its Pfizer (PFE) stake by 80% in Q2 2026, selling an estimated $52.1M and leaving 485,837 shares worth $11.7M. The position accounts for 0.19% of the portfolio, ranked #145.

Susquehanna Portfolio Strategies first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $69.5M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Susquehanna Portfolio Strategies held 485,837 shares of Pfizer worth $11.7M as of Q2 2026.
  • Susquehanna Portfolio Strategies sold 1,989,924 Pfizer shares in Q2 2026, an estimated $52.1M.
  • Pfizer made up 0.19% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #145 holding.
  • Susquehanna Portfolio Strategies first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
  • Susquehanna Portfolio Strategies's Pfizer position peaked at $69.5M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.